AHA Comments to FDA Re: Blood Glucose Monitoring Test Systems

AHA's comment on the Food and Drug Administration’s draft guidance on blood glucose monitoring test systems for prescription point-of-care use.

View the following letter for details. 

Related Resources

Other Resources
Mpox patients gain days of clarity, as Harborview Medical Center clinicians became adept at early identification
Case Studies
White Plains Hospital TeamSTEPPS Success Story
Other Resources
Resources | Team Training | Center
Other Resources
TeamSTEPPS Success Stories
Case Studies
UW Medicine TeamSTEPPS Success Story
Case Studies
Inova Health System TeamSTEPPS Success Story